
Dr. Farid Khan, BSc, MSc, PhD(Cantab).
Dr. Farid Khan is a remarkable bio-medtech entrepreneur and innovator, who obtained his PhD in protein folding from the University of Cambridge and previously worked for GlaxoSmithKline in drug discovery. He has developed technologies and therapies for diseases in the developed and the developing world.
In 2010, he founded his first biotech, Protein Technologies (http://www.protein-technologies.com) which developed novel biologics, biostimulants from microalgae, and industrial biocatlylsts. In 2012, Dr. Khan founded Pharmakure Ltd-a spin out from The University of Manchester (http://www.pharmakure.com)- which has developed drugs for Alzheimer's Disease.
More recently, he founded eLucid mHealth Ltd (https://www.elucid-mhealth.com), which measures medication adherence using a Bluetooth electronic pill dispensers- which is being trialed by the NHS and obtained Series A funding from Catapult Ventures. He has recently published on the discovery of new repurposed drugs for malaria and a number of rare diseases such as alkaptonuria (or 'black bone disease' which has no current treatment) and Multiple Systems Atrophy (a neurological disease).
He has secured £multi-million funds from private and public sources, formed key interdisciplinary collaborations with industry, academic institutions and charities (such as the Welcome Trust) including stakeholders in the UK's healthcare agenda. A visionary leader and respected scientist, with deep knowledge in the biotech industry. In 2013 Dr. Khan was awarded an Alumni Achievement Award from the University of Salford, in recognition of his work in science and engineering and 2014, he was awarded the Fazlur Rahman Khan award for excellence in engineering/science/technology by Prime Minister David Cameron. Dr. Khan has been interviewed by Bloomberg, The Guardian and the BBC and by a number of peer reviewed journals. In 2019, Dr. Khan formed Chief AI, a company focused on finding repurposed drugs using AI which has received InnovateUK and seed funding. In June, 2019, Dr. Khan was included in the top 100 Asian Stars in UK Tech-a definitive list by Diversity UK in association with KPMG.




